Low-dose ATRA supplementation abolishes PRM formation in rat liver and ameliorates ethanol-induced liver injury

Abstract

The effects of all-trans-retinoic acid (ATRA) in low doses supplementation on concentrations of polar retinoid metabolites (PRM) and retinoids in the ethanol-fed rat liver, and on hepatocyte injury were investigated. The rat model of alcoholic liver disease (ALD) was induced by intragastric infusion of ethanol, and then the rats were administrated with ATRA in two different doses (150 µg/kg body weight and 1.5 mg/kg body weight) for 4 weeks. Concentrations of retinoids in rat liver and plasma were determined by using HPLC. Liver tissues pathologic changes were observed under the light microscopy and electron microscopy. The serum transminases concentrations were measured. The results showed that the HPLC analysis of retinoids revealed that retinoids (vitamin A, RA, retinyl palmitate) concentrations in ethanol-fed rat liver and RA concentration in ethanol-fed rat plasma were markedly diminished (P<0.01) after ethanol feeding for 12 weeks. Furthermore, obvious peaks of PRM were formed in livers of ethanol-fed rats. ATRA 150 µg/kg supplementation in ethanol-fed rats for 4 weeks raised RA concentration in both liver and plasma, and also raised vitamin A concentration in liver to control levels, partially restored retinyl palmitate concentration (P<0.05) in liver. ATRA 1.5 mg/kg supplementation raised not only RA concentrations in liver and plasma but also retinyl palmitate concentrations in liver. However, the vitamin A concentration in liver of ATRA-supplemented rats (1.5 mg/kg) was higher than that of controls (P<0.05). The histologic observation of liver tissues indicated that ATRA treatment notably alleviated hepatocellular swelling, steatosis, the swelling of mitochondria and proliferation of smooth endoplasmic reticulum (SER). ATRA treatment greatly decreased levels of serum transaminases as compared with the only ethanol-fed group (P<0.05). It was concluded that low-dose ATRA treatment could restore retinoids concentrations and abolish the PRM formation in liver of ALD rats, and then ameliorate the injury of liver cells.

Keywords

alcoholic liver disease / ATRA / retinoids

References

[1] SeitzH. K.. Alcohol and retinoid metabolism. Gut, 2000, 47(6): 748-750

[2] LiuC., RussellR. M., SeitzH. K., et al.. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology, 2001, 120(1): 179-189

[3] DanZ. L., PopovY., PatsenkerE., et al.. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J, 2005, 19(7): 845-847

[4] ChungJ., ChavezP. R., RussellR. M., et al.. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats. Oncogene, 2002, 21(10): 1539-1547

[5] SundaresanP. R., CollinsT. F., WhitbyK. E., et al.. Effect of ethanol and vitamin A excess on vitamin A status in the liver, plasma and foetuses of pregnant rats. Food Chem Toxicol, 1994, 32(3): 247-254

[6] LiuC., ChungJ., SeitzH. K., et al.. Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats. Alcohol Clin Exp Res, 2002, 26(11): 1703-1709

[7] LeoM. A., LieberC. S.. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr, 1999, 69(6): 1071-1085

[8] WangX. D., LiuC., ChungJ., et al.. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) expression in rat liver. Hepatology, 1998, 28(3): 744-750

[9] ChungJ., LiuC., SmithD. E., et al.. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis, 2001, 22(8): 1213-1219

[10] WangX. D.. Chronic alcohol intake interferes with retinoid metabolism and signaling. Nutr Rev, 1999, 57(2): 51-59

[11] LeoM. A., KimC., LieberC. S.. Increased vitamin A in esophagus and other extrahepatic tissues after chronic ethanol consumption in the rat. Alcohol Clin Exp Res, 1986, 10(5): 487-492

[12] LieberC. S.. Microsomal ethanol-oxidizing system (ME OS): the first 30 years (1968–98) a review. Alcohol Clin Exp Res, 1999, 23(6): 991-1007

[13] KessovaI., CederbaumA. I.. CYP2E1: Biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med, 2003, 3(6): 509-518

[14] MishinV. M., RosmanA. S., BasuP., et al.. Chlorzoxazone pharmacokinetics as a marker of hepatic cytochrome P4502E1 in humans, 1998, 93(11): 2154-2161

[15] LiuC., RussellR. M., SeitzH. K., et al.. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology, 2001, 120(1): 179-189

[16] WangX. D., KrinskyN. I., RussellR. M.. Retinoic acid regulates retinol metabolism via feedback inhibition of retinol oxidation and stimulation of retinol esterification in ferret liver. J Nutr, 1993, 123(7): 1277-1285

[17] MatsuuraT., RossA. C.. Regulation of hepatic lecithin: retinol acyltransferase activity by retinoic acid. Arch Biochem Biophys, 1993, 301(2): 221-227

[18] WagnerJ., DechowC., MorathC., et al.. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol, 2000, 11(8): 1479-1487

[19] DavisB. H., KramerR. T., DavidsonN. O.. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest, 1990, 86(6): 2062-2070